On November 13-15, 2013, the 71st Chinese exhibition for the trade of worldwide pharmaceutical raw material, intermediate, packaging and medical equipment (“API China”) was held in Suzhou. CGE Healthcare, a CGE brand established for CGE pharmaceuticals and healthcare sector, participated in the exhibition together with its seven subsidiaries including Jiangsu Grand Pharm&Chem Co., Ltd and Baoding Jiufu Biochemical Co., Ltd., etc.

API China is the largest industrial exhibition for the upstream products in the pharmaceutical industry of China, in which the latest products and cutting-edge technologies are exhibited. It has been expanding continuously for the last 40 years. There were over 1000 pharmaceutical raw material producers, 300 plus pharmaceutical packaging providers, more than 200 pharmaceutical equipment manufacturers and over 30,000 pharmaceutical industry professionals at home and abroad participated this year. API China provides pharmaceutical industry a one-stop trading platform for procurement, services and information exchange

Through integration of dozens of member companies, CGE Healthcare has formed four major industrial platforms in fermentation, synthetic chemistry, modern Chinese medicine and biopharmaceuticals. It owns near 1,000 products covering both domestic and international markets and has gradually developed into a top healthcare brand with integrated pharmaceutical R&D, manufacturing and distribution. 

CGE Healthcare's first exhibition attracted many major customers for business talks, keys products introductions, and for major concerns in sales policies, corporate development，etc. to get addressed. Frank and cordial dialogues with customers created many opportunities for future business growth.

The participation at API China not only helped CGE Healthcare better understand the market development trend and expand business cooperation, but also helped further enhance CGE Healthcare brand, and make its key products better known in industry.